· 2 min read
Vaginal PDRN Pessaries Linked to Repair of Cervical Tissue in Small Patient Study
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer
· 2 min read
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Based on the PubMed abstract — the full text of this paper was not freely available.
Pasquinucci and Contini, writing in Annali di ostetricia, ginecologia, medicina perinatale in 1990, studied whether polydeoxyribonucleotide (PDRN), a molecule made of chains of DNA fragments, could help repair a common cervical condition called ectopia, where the inner glandular lining extends onto the outer surface of the cervix.
The researchers used a computer-linked colposcope (a camera system for examining the cervix) to photograph, digitize and measure the irregular tissue areas before and after treatment. Twelve outpatients with cervical ectopia received a monthly course of 12 vaginal pessaries, each containing 5 mg of PDRN (a product named Polides 5), inserted from day 7 to day 18 of the menstrual cycle, repeated for three months.
In 9 of the 12 patients, the glandular tissue area shrank from the first month onward, replaced by the normal protective surface layer; by the end of treatment this covered an average of 55% of the affected area (range 33–78%). The remaining 3 patients showed no change.
This is a small, uncontrolled clinical observation without a comparison group, so it cannot show that PDRN itself, rather than natural healing or the colposcopic monitoring process, caused the improvement.
Our reflection
This early clinical report is a reminder that PDRN's tissue-repair properties have been investigated in gynecological contexts for decades, well before today's interest in skin and wound applications. At Havdis, we see such historical studies as part of a long, cumulative record that helped establish PDRN as a molecule worth continued scientific attention, even as methods and evidence standards have since advanced considerably.
Source
Pasquinucci C, Contini V (1990). Annali di ostetricia, ginecologia, medicina perinatale.
This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.
Related
A 1990 study tested PDRN vaginal suppositories in 30 women with cervical ectropion, reporting on symptoms, tolerability and tissue markers.
Read more →A 1990 clinical trial on PDRN vaginal ovules after cervical laser vaporization and cauterization, examining recovery via colposcopy and Pap smear follow-up.
Read more →A 1993 European Journal of Pharmacology study on how defibrotide, a polydeoxyribonucleotide, binds adenosine A1 and A2 receptors in lab experiments.
Read more →